5,563 reports of this reaction
6.2% of all HYDROCODONE BITARTRATE reports
#7 most reported adverse reaction
DRUG WITHDRAWAL SYNDROME is the #7 most commonly reported adverse reaction for HYDROCODONE BITARTRATE, manufactured by Purdue Pharma LP. There are 5,563 FDA adverse event reports linking HYDROCODONE BITARTRATE to DRUG WITHDRAWAL SYNDROME. This represents approximately 6.2% of all 89,079 adverse event reports for this drug.
Patients taking HYDROCODONE BITARTRATE who experience drug withdrawal syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG WITHDRAWAL SYNDROME is moderately reported among HYDROCODONE BITARTRATE users, representing a notable but not dominant share of adverse events.
In addition to drug withdrawal syndrome, the following adverse reactions have been reported for HYDROCODONE BITARTRATE:
The following drugs have also been linked to drug withdrawal syndrome in FDA adverse event reports:
DRUG WITHDRAWAL SYNDROME has been reported as an adverse event in 5,563 FDA reports for HYDROCODONE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG WITHDRAWAL SYNDROME accounts for approximately 6.2% of all adverse event reports for HYDROCODONE BITARTRATE, making it a notable side effect.
If you experience drug withdrawal syndrome while taking HYDROCODONE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.